Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Inari Medical stock
Learn how to easily invest in Inari Medical stock.
Inari Medical Inc is a medical devices business based in the US. Inari Medical shares (NARI) are listed on the NASDAQ and all prices are listed in US Dollars. Inari Medical employs 456 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Inari Medical
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NARI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Inari Medical stock price (NASDAQ: NARI)Use our graph to track the performance of NARI stocks over time.
Inari Medical shares at a glance
|Latest market close||$67.50|
|52-week range||$65.83 - $127.42|
|50-day moving average||$84.34|
|200-day moving average||$87.68|
|Wall St. target price||$121.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.28|
Buy Inari Medical shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Inari Medical stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Inari Medical price performance over time
|1 week (2022-01-20)||-8.15%|
|1 month (2021-12-28)||-26.62%|
|3 months (2021-10-28)||-24.58%|
|6 months (2021-07-28)||-24.74%|
|1 year (2021-01-28)||-29.14%|
|2 years (2020-01-24)||N/A|
|3 years (2019-01-24)||N/A|
|5 years (2017-01-24)||N/A|
Is Inari Medical stock undervalued or overvalued?
Valuing Inari Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inari Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inari Medical's P/E ratio
Inari Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 242x. In other words, Inari Medical shares trade at around 242x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Inari Medical's EBITDA
Inari Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.3 million.
The EBITDA is a measure of a Inari Medical's overall financial performance and is widely used to measure a its profitability.
Inari Medical financials
|Revenue TTM||$242.4 million|
|Operating margin TTM||10.62%|
|Gross profit TTM||$127.8 million|
|Return on assets TTM||6.46%|
|Return on equity TTM||7.38%|
|Market capitalisation||$3.4 billion|
TTM: trailing 12 months
Inari Medical share dividends
We're not expecting Inari Medical to pay a dividend over the next 12 months.
Inari Medical overview
Inari Medical, Inc. , a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc.
Inari Medical in the news
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questionsWhat percentage of Inari Medical is owned by insiders or institutions?
Currently 19.932% of Inari Medical shares are held by insiders and 83.053% by institutions. How many people work for Inari Medical?
Latest data suggests 456 work at Inari Medical. When does the fiscal year end for Inari Medical?
Inari Medical's fiscal year ends in December. Where is Inari Medical based?
Inari Medical's address is: 9 Parker, Irvine, CA, United States, 92618 What is Inari Medical's ISIN number?
Inari Medical's international securities identification number is: US45332Y1091
More guides on Finder
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market has lost $1.5 trillion in value — time to buy?
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin tumbles past $40,000, altcoins follow
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s Pavia plot sale shows land rush is on in the metaverse
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Ask an Expert